It took more than a decade
after zolpidem launched for the FDA to formally address the issue; in 2013, it halved the recommended dose for women.
Not exact matches
The FDA had determined that 15 percent of the 5.7 million American women using
zolpidem products (the active ingredient in Ambien) were experiencing driving impairment eight hours
after taking the drug, compared with 3 percent of the 3.5 million male
zolpidem users.
According to Clauss,
after taking his first, 10 milligram dose of
zolpidem the patient could meaningfully interact with family, friends and strangers.